{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T04:15:23Z","timestamp":1792556123301,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","thegreenjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.radonc.2024.110421","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T23:55:43Z","timestamp":1720655743000},"page":"110421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Secondary cancer risk in six anatomical sites when using PAT, IMPT, and VMAT\/IMRT radiotherapy"],"prefix":"10.1016","volume":"199","author":[{"given":"Perry B.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Mamalui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrik","family":"Brodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2024.110421_b0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13014-020-1476-9","article-title":"Improve the dosimetric outcome in bilateral head and neck cancer (HNC) treatment using spot-scanning proton arc (SPArc) therapy: a feasibility study","volume":"15","author":"Liu","year":"2020","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110421_b0010","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1021\/acssensors.0c01879","article-title":"Impact of multiple beams on plan quality, linear energy transfer distribution, and plan robustness of intensity modulated proton therapy for lung cancer","volume":"6","author":"Shang","year":"2021","journal-title":"ACS Sens"},{"key":"10.1016\/j.radonc.2024.110421_b0015","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/mp.16098","article-title":"Spot scanning proton arc therapy reduces toxicity in oropharyngeal cancer patients","volume":"50","author":"de Jong","year":"2023","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2024.110421_b0020","article-title":"Linear energy transfer incorporated spot-scanning proton arc therapy optimization: a feasibility study","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2024.110421_b0025","doi-asserted-by":"crossref","first-page":"806","DOI":"10.3109\/0284186X.2011.582514","article-title":"Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma","volume":"50","author":"Brodin","year":"2011","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2024.110421_b0030","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3389\/fonc.2020.00989","article-title":"Secondary malignancy risk following proton vs. X-ray treatment of mediastinal malignant lymphoma: a comparative modeling study of thoracic organ-specific cancer risk","volume":"10","author":"Konig","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2024.110421_b0035","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.radonc.2020.05.035","article-title":"The risk for developing a secondary cancer after breast radiation therapy: Comparison of photon and proton techniques","volume":"149","author":"Paganetti","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110421_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14338\/IJPT-19-00076.1","article-title":"Predicted secondary malignancies following proton versus photon radiation for oropharyngeal cancers","volume":"6","author":"Jain","year":"2020","journal-title":"Int J Part Ther"},{"key":"10.1016\/j.radonc.2024.110421_b0045","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejmp.2017.03.019","article-title":"Comparative study of the calculated risk of radiation-induced cancer after photon- and proton-beam based radiosurgery of liver metastases","volume":"42","author":"Mondlane","year":"2017","journal-title":"Phys Med"},{"key":"10.1016\/j.radonc.2024.110421_b0050","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3109\/0284186X.2015.1061691","article-title":"Risk of radiation-induced secondary rectal and bladder cancer following radiotherapy of prostate cancer","volume":"54","author":"Stokkevag","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2024.110421_b0055","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1088\/0031-9155\/54\/8\/002","article-title":"The risk of developing a second cancer after receiving craniospinal proton irradiation","volume":"54","author":"Newhauser","year":"2009","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2024.110421_b0060","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1088\/0031-9155\/57\/19\/6047","article-title":"Assessment of radiation-induced second cancer risks in proton therapy and IMRT for organs inside the primary radiation field","volume":"57","author":"Paganetti","year":"2012","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2024.110421_b0065","doi-asserted-by":"crossref","first-page":"7117","DOI":"10.1088\/0031-9155\/57\/21\/7117","article-title":"Risk of radiogenic second cancers following volumetric modulated arc therapy and proton arc therapy for prostate cancer","volume":"57","author":"Rechner","year":"2012","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2024.110421_b0070","doi-asserted-by":"crossref","first-page":"6987","DOI":"10.1088\/0031-9155\/55\/23\/S02","article-title":"Estimate of the uncertainties in the relative risk of secondary malignant neoplasms following proton therapy and intensity-modulated photon therapy","volume":"55","author":"Fontenot","year":"2010","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2024.110421_b0075","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13014-016-0717-4","article-title":"A treatment planning study of proton arc therapy for para-aortic lymph node tumors: dosimetric evaluation of conventional proton therapy, proton arc therapy, and intensity modulated radiotherapy","volume":"11","author":"Rah","year":"2016","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110421_b0080","unstructured":"National Research Council, Health Risks from Exposure to Low Levels of Ionizing Radiation: BEIR VII Phase 2. 2006, Washington, DC: The National Academies Press. 422."},{"key":"10.1016\/j.radonc.2024.110421_b0085","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.ijrobp.2004.12.040","article-title":"Estimation of radiation-induced cancer from three-dimensional dose distributions: concept of organ equivalent dose","volume":"61","author":"Schneider","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110421_b0090","article-title":"Risk of second primary cancer from proton arc therapy of pediatric brain tumors","volume":"27","author":"Toussaint","year":"2023","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110421_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-4682-8-27","article-title":"Site-specific dose-response relationships for cancer induction from the combined Japanese A-bomb and Hodgkin cohorts for doses relevant to radiotherapy","volume":"8","author":"Schneider","year":"2011","journal-title":"Theor Biol Med Model"},{"key":"10.1016\/j.radonc.2024.110421_b0100","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1118\/1.3089792","article-title":"Mechanistic model of radiation-induced cancer after fractionated radiotherapy using the linear-quadratic formula","volume":"36","author":"Schneider","year":"2009","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2024.110421_b0105","unstructured":"International Commission on Radiological Protection. The 2007 Recommendations of the International Commission on Radiological Protection. ICRP publication 103, in Ann ICRP, J. Valentin, Editor; 2007. p. 1-332."},{"key":"10.1016\/j.radonc.2024.110421_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109670","article-title":"Proton arc therapy increases the benefit of proton therapy for oropharyngeal cancer patients in the model based clinic","volume":"184","author":"de Jong","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110421_b0115","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1080\/0284186X.2021.1892183","article-title":"Is proton beam therapy ready for single fraction spine SBRS? - a feasibility study to use spot-scanning proton arc (SPArc) therapy to improve the robustness and dosimetric plan quality","volume":"60","author":"Liu","year":"2021","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2024.110421_b0120","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ac55a6","article-title":"Fast robust optimization of proton PBS arc therapy plans using early energy layer selection and spot assignment","volume":"67","author":"Engwall","year":"2022","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.radonc.2024.110421_b0125","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/0284186X.2017.1358463","article-title":"Have we reached proton beam therapy dosimetric limitations? - A novel robust, delivery-efficient and continuous spot-scanning proton arc (SPArc) therapy is to improve the dosimetric outcome in treating prostate cancer","volume":"57","author":"Ding","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2024.110421_b0130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1748-717X-6-67","article-title":"Dose-response relationship for breast cancer induction at radiotherapy dose","volume":"6","author":"Schneider","year":"2011","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2024.110421_b0135","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.zemedi.2010.03.008","article-title":"Dose-response relationship for lung cancer induction at radiotherapy dose","volume":"20","author":"Schneider","year":"2010","journal-title":"Z Med Phys"},{"key":"10.1016\/j.radonc.2024.110421_b0140","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijrobp.2013.04.030","article-title":"Incidence of second malignancies among patients treated with proton versus photon radiation","volume":"87","author":"Chung","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110421_b0145","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1002\/cncr.32938","article-title":"Second cancer risk after primary cancer treatment with three-dimensional conformal, intensity-modulated, or proton beam radiation therapy","volume":"126","author":"Xiang","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2024.110421_b0150","unstructured":"National Research Council. Health Effects of Exposure to Low Levels of Ionizing Radiation: BEIR V, Washington (DC); 1990."}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024006911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024006911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T05:48:06Z","timestamp":1729057686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814024006911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":30,"alternative-id":["S0167814024006911"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110421","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secondary cancer risk in six anatomical sites when using PAT, IMPT, and VMAT\/IMRT radiotherapy","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110421","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110421"}}